Skip to main content
SpringerLink
Log in

Authors’ Reply to Braillon et al. ’s Comment on “Should Antidepressants be Avoided in Pregnancy?”

  • Letter to the Editor
  • Published:
Drug Safety Aims and scope Submit manuscript

The Original Article was published on 27 April 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Braillon A, Bewley S, Blumsohn A, Naudet F. Comment on: Should antidepressants be avoided in pregnancy? Drug Saf. 2023. https://doi.org/10.1007/s40264-023-01308-1.

  2. Besag F, Dodd S. When can a drug be declared “safe”? Curr Drug Saf. 2010;5(2):112–3.

    Article  PubMed  Google Scholar 

  3. Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62:345–54.

    Article  PubMed  Google Scholar 

  4. Kolding L, Ehrenstein V, Pedersen L, Sandager P, Petersen OB, Uldbjerg N, et al. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study. BJOG: Int J Obstet Gynaecol. 2021;128(12):1949–57.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. East London NHS Foundation Trust, 9 Rush Court, Bedford, MK40 3JT, UK

    Frank M. C. Besag

  2. University College London, London, UK

    Frank M. C. Besag

  3. King’s College London, London, UK

    Frank M. C. Besag

  4. East London NHS Foundation Trust, Bedford, UK

    Michael J. Vasey

Authors
  1. Frank M. C. Besag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Vasey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank M. C. Besag.

Ethics declarations

Funding

No funding was received in relation to the preparation of this manuscript.

Conflicts of interest

The authors have no conflicts of interest to declare.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

Not applicable.

Code availability

Not applicable.

Authors’ contributions

Both authors contributed to the drafting of the manuscript and approved the final version.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Besag, F.M.C., Vasey, M.J. Authors’ Reply to Braillon et al. ’s Comment on “Should Antidepressants be Avoided in Pregnancy?”. Drug Saf 46, 617–618 (2023). https://doi.org/10.1007/s40264-023-01309-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-023-01309-0

Search

Navigation